Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
200,000 unrestricted shares, 100k @ DTC. Only product ever to receive breakthough device designation by FDA for the mitigation of Alzheimers sysmptoms of agitation and depression.
Share Structure as of 5-7-19
Authorized Shares - 66,666,667
Outstanding Shares - 2,669,602
Restricted - 2,461,694
Unrestricted - 207,908
Held at DTC - 107,406
Market Cap - 2,349,250
52WK RANGE 0.50 - 16.80
DTHR: effective Sept. 25,2018 a one for 20 reverse split:
http://otce.finra.org/DLSymbolNameChanges
DTHR .42 news out FDA breakthrough designation:
https://www.otcmarkets.com/stock/DTHR/news/Dthera-Sciences-Receives-FDA-Breakthrough-Device-Designation-For-Its-Alzheimers-Focused-Development-Stage-Product-DTHR-A?id=201805
I've said this before and I'll say it again. This one is a hidden gem, they're working to solve a real problem.
$DTHR keep an eye on guys.
Anybody know if they have any type of patent on the app or the process?? This concerns me as it’s basically a glorified picture slide show that you can do on ANY tablet...
I think so too...this could help so many people.
DTHR
That was a good interview Jedi.
$DTHR CEO Ed Cox of Dthera Sciences Interview on Fox business Network 3/25/18 https://youtu.be/PvIWUXPqjmw via @YouTube
People will start taking notice of this revolutionary drug-free treatment from DTHR
The Company’s CEO Ed Cox, recently co-chaired the Digital Therapeutics and Digital Summit, an event designed to inspire future leaders in this new field of medicine, aimed to define the current and future landscape of this rapidly emerging industry. The event drew over 100 digital medicine executives, pharmaceutical leaders, and venture capitalists. Mr. Cox will be summarizing the results of that event and updating shareholders on the Company’s vision for the future.
DTHR
yes we are and that shows that people are taking notice here.
DTHR
starting to get volume .51's nice accumulation
DTHR
That was huge exposure ncytraydr!
LOL I know...I am one of them..
DTHR
I think they are very wise to move in that direction.
Reminiscence therapy improves cognitive functions & reduces depressive symptoms in elderly people w/ #Dementia http://www.ncbi.nlm.nih.gov/pubmed/26341034
DTHR
Americans over the age of 65 increases from 53 million today, to 88 million by 2050.
DTHR
Dthera Developing First Digital Therapeutics to Address Issues Associated with Dementia
DTHR
Here is how Reminiscence Therapy works..
Reminiscence therapy improves cognitive functions & reduces depressive symptoms in elderly people w/ #Dementia http://www.ncbi.nlm.nih.gov/pubmed/26341034
DTHR is wise to specialize in this medicine alternative
Their number one product will improve quality of life in patients with Alzheimer's & Dementia https://reminx.com/
$DTHR
big development here: Dthera Developing First Digital Therapeutics to Address Issues Associated with Dementia https://finance.yahoo.com/news/dthera-sciences-commends-alzheimers-association-120500837.html
DTHR
Their product will help so many people. https://reminx.com/
DTHR
Quality of life is so important for the patients.
www.ReminX.com
DTHR
Yes they are! DTHR is looking exciting for this week
That's true. It has been very labor intensive until DTHR's ReminX came around. https://reminx.com/
Off to a green start...that is great to see.
DTHR
growth of the digital therapeutic devices market is primarily driven by increasing use of technology for therapeutics of medical conditions.
DTHR
The total global cost of dementia in 2018 is estimated to be $818 billion.
DTHR
ReminX is an #AI powered therapeutic designed to improve quality of life in patients with #Alzheimer's & #Dementia. Nice product for DTHR! https://reminx.com/
it wont be long before everyone catches on! I predict some nice studies coming out for DTHR's product
check out the company site http://www.dthera.com
DTHR
Good morning everyone. the topic here is DTHR: Alzheimers Dementia, Reminiscence Therapy, real issues facing the elderly population! DTHR is coming to market with a very intriguing product in ReminX
DTHR's Reminiscence Therapy can be such a big help in the patient and their family's lives.
Dthera Developing First Digital Therapeutics to Address Issues Associated with Dementia https://finance.yahoo.com/news/dthera-sciences-commends-alzheimers-association-120500837.html
DTHR
Check out this video https://www.facebook.com/reminiscencetherapy/videos/1068030929999325/
DTHR
That is a huge problem for those suffering with these ailments.
DTHR
Dthera Sciences top product for release in MAY 2018 will improve quality of life in patients with Alzheimer's & Dementia https://reminx.com/
$DTHR
next generation of health care having a huge digital tech effect
DTHR
Calling for a run up this week on DTHR
worldwide cost of dementia in 2018 is estimated to be $818 billion, huge opportunity for DTHR to help
Very nice Let's Roll! Reminiscence Therapy (RT) is usually given to relieve stress and anxiety.
$DTHR
A massive demographic shift is underway in the U.S. which will see the elderly population double to 70 million by 2030, up from 40 million in 2010. This is why I like DTHR.
Nice Bud! check out this video with the DTHR CEO here https://vimeo.com/226190902
2018 Alzheimer's Disease Facts and Figures report stated that the overall costs to care for the estimated 5.7 million Americans with Alzheimer's disease and other dementias will reach a total of more than $277 billion in 2018 for the second year in a row. This bodes well for shareholders.
DTHR
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
788
|
Created
|
01/03/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |